DMK PHARMACEUTICALS Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996

SEC filing history

Showing 176-200 of 775 matching filings.

Per page
25
Current page
8
NT 10-Q File 001-36242

NOTICE OF INABILITY TO TIMELY FILE

Filing date
17 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-36242

AMENDED 10-K

Filing date
30 Apr 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
15 Apr 2021
Reporting date
15 Apr 2021
Next action
Verify source filing
10-K File 001-36242

ANNUAL REPORT

Filing date
15 Apr 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
15 Apr 2021
Reporting date
14 Apr 2021
Next action
Verify source filing
NT 10-K File 001-36242

NOTICE UNDER RULE 12B25 OF INABILITY TO TIMELY FILE

Filing date
31 Mar 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Feb 2021
Reporting date
21 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Feb 2021
Reporting date
21 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Feb 2021
Reporting date
21 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Feb 2021
Reporting date
21 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-45279

SCHEDULE 13G/A

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
09 Feb 2021
Reporting date
09 Feb 2021
Next action
Verify source filing
424B5 File 333-226100

PROSPECTUS

Filing date
29 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
29 Jan 2021
Reporting date
29 Jan 2021
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
28 Jan 2021
Reporting date
28 Jan 2021
Next action
Verify source filing
424B5 File 333-226100

PROSPECTUS

Filing date
28 Jan 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
28 Jan 2021
Reporting date
28 Jan 2021
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
26 Jan 2021
Reporting date
26 Jan 2021
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
22 Jan 2021
Reporting date
21 Jan 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .